Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy
- PMID: 8053652
- DOI: 10.1002/ana.410360208
Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy
Abstract
We used positron emission tomography with [18F]fluorodeoxyglucose to study local cerebral metabolic rates for glucose (ICMRglc) in patients with multiple system atrophy (MSA), sporadic olivopontocerebellar atrophy (sOPCA), and dominantly inherited olivopontocerebellar atrophy (dOPCA) in comparison with normal control subjects. IN MSA, absolute lCMRglc was significantly decreased in the brainstem, cerebellum, putamen, thalamus, and cerebral cortex. In sOPCA, absolute lCMRglc was significantly decreased in the brainstem, cerebellum, putamen, thalamus, and cerebral cortex. In dOPCA, absolute lCMRglc was significantly decreased in the brainstem and cerebellum but not in the other structures. Examination of lCMRglc normalized to the cerebral cortex in comparison with normal controls revealed in MSA significant decreases in the brainstem, cerebellum, and putamen but, in both sOPCA and dOPCA, significant decreases only in the brainstem and cerebellum. The findings indicate that these three disorders all show a marked decrease of lCMRglc in the brainstem and cerebellum but differ in the degree of hypometabolism in forebrain and cerebral cortical structures. The results are consistent with the possibility that, in many cases, sOPCA will evolve into MSA. Moreover, positron emission tomography may provide helpful diagnostic information in these neurodegenerative diseases.
Similar articles
-
Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.Ann Neurol. 1996 Dec;40(6):885-92. doi: 10.1002/ana.410400610. Ann Neurol. 1996. PMID: 9007093
-
A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET.Neurology. 1995 Jul;45(7):1345-52. doi: 10.1212/wnl.45.7.1345. Neurology. 1995. PMID: 7617196
-
Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings.Ann Neurol. 1988 Jun;23(6):547-54. doi: 10.1002/ana.410230604. Ann Neurol. 1988. PMID: 3261572
-
Olivopontocerebellar atrophy: toward a better nosological definition.Mov Disord. 2006 Oct;21(10):1607-13. doi: 10.1002/mds.21052. Mov Disord. 2006. PMID: 16874757 Review.
-
Neuroimaging Applications in Chronic Ataxias.Int Rev Neurobiol. 2018;143:109-162. doi: 10.1016/bs.irn.2018.09.011. Epub 2018 Oct 29. Int Rev Neurobiol. 2018. PMID: 30473193 Review.
Cited by
-
Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):517-23. doi: 10.1136/jnnp.73.5.517. J Neurol Neurosurg Psychiatry. 2002. PMID: 12397143 Free PMC article.
-
Functional imaging with positron emission tomography in multiple system atrophy.J Neural Transm (Vienna). 2005 Dec;112(12):1647-55. doi: 10.1007/s00702-005-0351-z. Epub 2005 Aug 5. J Neural Transm (Vienna). 2005. PMID: 16082507 Review.
-
An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention.J Neurol. 2020 Sep;267(9):2754-2770. doi: 10.1007/s00415-020-09881-6. Epub 2020 May 20. J Neurol. 2020. PMID: 32436100 Free PMC article. Review.
-
Multiple system atrophy: pathophysiology and management.CNS Drugs. 2001;15(11):839-52. doi: 10.2165/00023210-200115110-00003. CNS Drugs. 2001. PMID: 11700149 Review.
-
Brain SPECT imaging in multiple system atrophy.J Neural Transm (Vienna). 2005 Dec;112(12):1635-45. doi: 10.1007/s00702-005-0382-5. J Neural Transm (Vienna). 2005. PMID: 16284908 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical